The Online Investor
OLI Premium
Contrarian Outlook
Stock Option Ideas
Preferred Stock Newsletter
ChartZero.com
Drugs & Pharmaceuticals IPOs image Drugs & Pharmaceuticals IPOs » By The Online Investor Staff, updated Wed., Feb. 12, 5:42 PM
Recent initial public offerings in the Drugs & Pharmaceuticals IPOs category.

Slide #1. Clearside Biomedical, Inc. Initial Public Offering

Company: Clearside Biomedical, Inc.
Proposed Symbol: CLSD
Shares Offered: 7,200,000
Price Per Share: $7.00
Over-Allotment: 1,080,000
Description: Clearside Biomedical, Inc. (NASDAQ:CLSD), a late-stage clinical biopharmaceutical company developing first-in-class drug therapies to treat blinding diseases of the eye, today announced the pricing of its initial public offering of 7,200,000 shares of its common stock at a public offering price of $7.00 per share. In addition, Clearside has granted the underwriters a 30-day option to purchase up to an additional 1,080,000 shares of common stock at the public offering price, less underwriting discounts and commissions. The shares are scheduled to begin trading on the NASDAQ Global Market on June 2, 2016 under the ticker symbol "CLSD." All of the common stock is being offered by Clearside.

IPOs: Clearside Biomedical, Inc.

List of Drugs & Pharmaceuticals IPOs in this Slideshow:
Company                                 Ticker    IPO Date
Enanta Pharmaceuticals, Inc             ENTA      3/21/2013
Atossa Genetics, Inc.                   ATOS      11/8/2012
Zoetis                                  ZTS       
PTC Therapeutics, Inc.                  PTCT      
Prosensa Holding B.V.                   RNA       
Agios Pharmaceuticals, Inc.             AGIO      
Evoke Pharma, Inc.                      EVOK      
Karyopharm Therapeutics Inc.            KPTI      
MacroGenics, Inc                        MGNX      
Xencor                                  XNCR      
ADMA Biologics                          ADMA      
Cara Therapeutics                       CARA      
Ultragenyx Pharmaceutical Inc.          RARE      
Intra-Cellular Therapies                ITCI      
Akebia Therapeutics                     AKBA      
Phibro Animal Health Corporation        PAHC      
Agile Therapeutics, Inc.                AGRX      
MediWound Ltd                           MDWD      
Phibro Animal Health Corporation        PAHC      
Aldeyra Therapeutics                    ALDX      
Amphastar Pharmaceuticals, Inc.         AMPH      
Karyopharm Therapeutics Inc.            KPTI      
Affimed                                 AFMD      
SAGE Therapeutics, Inc                  SAGE      
Ocular Therapeutix                      OCUL      
Marinus Pharmaceuticals, Inc.           MRNS      
ProQR Therapeutics                      PRQR      
Dermira                                 DERM      
Ascendis Pharma A/S                     ASND      
Blueprint Medicines Corporation         BPMC      
Xbiotech                                XBIT      
Viking Therapeutics, Inc.               VKTX      
Collegium Pharmaceutical, Inc.          COLL      
Seres Therapeutics, Inc.                MCRB      
vTv Therapeutics Inc.                   VTVT      
Aclaris Therapeutics, Inc.              ACRS      
CytomX Therapeutics, Inc.               CTMX      
WAVE Life Sciences Ltd.                 WVE       
Mesoblast Limited                       MESO      
Corvus Pharmaceuticals, Inc.            CRVS      
Merus B.V.                              MRUS      
Clearside Biomedical, Inc.              CLSD      

February 12, 2025    5:42 PM Eastern

Drugs & Pharmaceuticals IPOs | www.TheOnlineInvestor.com | Copyright © 1998 - 2025, All Rights Reserved

Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes, powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.